Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05017246 · ClinicalTrials.gov registry record · Phase 2
Comparing Intrathecal Morphine and Intraoperative Lidocaine Infusion to Epidural Anesthesia With Postoperative PCA for Patients Undergoing Exploratory Laparotomy
A Phase 2 study, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- Phase 2
- Development phase
- 110
- Enrollment target
NCT05017246 is a Phase 2 study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 110 participants.
The verdict
NCT05017246, a Phase 2 study, was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 110 participants
- Enrollment target
Study Summary
To determine if opioid consumption postoperatively among patients undergoing non-emergent laparotomy by the gynecologic oncology service who receive intrathecal morphine with intraoperative lidocaine (IML) infusion are lower than patients who have epidural anesthesia with PCA (EPCA).
Interventions
- DRUG Bupivacaine
- DRUG Lidocaine
- DRUG Morphine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2022-01-18 |
| Est. Completion | 2024-08-29 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05017246
The ClinicalTrials.gov registry entry for NCT05017246 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Bupivacaine is the first listed.
NCT05017246 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05017246 about?
NCT05017246 is a clinical study titled "Comparing Intrathecal Morphine and Intraoperative Lidocaine Infusion to Epidural Anesthesia With Postoperative PCA for Patients Undergoing Exploratory Laparotomy". To determine if opioid consumption postoperatively among patients undergoing non-emergent laparotomy by the gynecologic oncology service who receive intrathecal morphine with intraoperative lidocaine (IML) infusion are lower than patients who have epidural anesthesia with PCA (EPCA).
What is the current status of trial NCT05017246?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 110 participants. The study started on 2022-01-18. Estimated completion is 2024-08-29.
What interventions are being tested in trial NCT05017246?
The interventions under investigation include: Bupivacaine (DRUG), Lidocaine (DRUG), Morphine (DRUG).
Who is sponsoring clinical trial NCT05017246?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.